Table 3.
Variant | Gene/location | Ref. Allele | Test Allele | MAF (%) in PNAT2 | MAF (%) in KIS3 | Beta (SE); P-Value in PNAT2a | Beta (SE); P-Value in KIS3a | Beta (SE); P-Value in Meta-Analysisb |
---|---|---|---|---|---|---|---|---|
rs12459249 | ~9.5kb 3’ of CYP2A6 | T | C | 31.2 | 35.9 | 0.60 (0.063); 1.16e-19 | 0.61 (0.064); 1.21e-19 | 0.59 (0.045); 1.47e-39 |
rs111645190 | ~5.5kb 5’ of CYP2A6 | G | A | 13.7 | 14.2 | -0.63 (0.088); 3.29e-12 | -0.65 (0.089); 1.57e-12 | -0.62 (0.06); 1.06e-23 |
MAF, minor allele frequency
Adjusted for cohort-specific principal components 1 and 2
In PNAT2, GWAS results were adjusted for principal components 1 and 2, sex, age, BMI, and the use of mentholated cigarettes. In KIS3, GWAS results were adjusted for principal components 1 and 2, sex, age, and BMI. The genomic inflation factor score (λ) in each population was 1 and therefore not adjusted for in the meta-analysis.